Mon 7 April 2014, 9:24 am
3Fox International managing director Toby Fox chaired the Invest Glasgow Life Science seminar in London last week (3 April).
The event brought together developers, occupiers and local and national government agencies to discuss the Glasgow BioCorridor, an area of less than 50 miles from the BioCity Scotland facility in Newhouse, North Lanarkshire to Glasgow City with its universities, research institutes and hospitals, Renfrewshire with Thermo Fisher Scientific (previously Life Technologies) and west to the major GlaxoSmithKline facility and Irvine Bay Regeneration’s i3 Enterprise Area in Irvine, North Ayrshire.
Kevin Moore, OBE, chairman of the Glasgow Economic Leadership Life Science Work Stream, set out ambitious plans for the Glasgow BioCorridor to generate annual revenue of £2 billion by 2020. Established last year, the BioCorridor area was already third in the UK for attracting life science foreign direct investment projects, with 10 schemes securing £73 million and 294 jobs since 2008. Over 300 life science companies are based in the area and the £1 billion South Glasgow Hospital campus under development is Europe’s biggest hospital project.
Glasgow Chamber of Commerce chief executive Stuart Patrick observed that Glasgow is home to 133,000 students, 20,000 of them in life sciences, producing the UK’s brightest workforce outside London. Four universities produce 5,700 life sciences graduates a year.
The Invest Glasgow Life Sciences speaker panel (l-r): Kevin Moore, OBE, of the Glasgow Economic Leadership Life Science Work Stream; Glasgow Chamber of Commerce's Stuart Patrick; Glasgow City Council's Anne Murray; professor Anna Dominiczak, OBE, of University of Glasgow; and Thermo Fisher Scientific's Peter Silvester
Glasgow City Council business relationship manager Anne Murray described a fast-track planning service that took major projects to approval within seven weeks, along with grants and other financial incentives for businesses locating in Glasgow. And professor Anna Dominiczak, OBE, outlined the pioneering work of the new Stratified Medicine Scotland Innovation Centre, and the public/private sector collaboration that led to its formation. A world-leading cardiovascular researcher, professor Dominiczak is vice-principal and head of college of medical, veterinary and life sciences at the University of Glasgow.
One of the university’s partners in developing the Innovation centre was Thermo Fisher Scientific. Peter Silvester is that company’s president of biosciences, Life Sciences Solutions Group, and he explained to delegates why the $16 billion company had chosen Glasgow as the location of its European headquarters, highlighting the city’s skills base.
Chairing the event, Fox said: “Glasgow is a great city, the fourth largest in the UK, which gives it a significance that is not always recognised. There has been £6 billion of capital investment there since 2011, which is substantial to say the least – the inward investment programme was voted the best in Europe this year by the Financial Times. It almost goes without saying that it is a pleasure to work with such an excellent team.”
For more information click here.
(l-r) Kevin Moore, OBE, chairman of the Glasgow Economic Leadership Life Science Work Stream; Toby Fox; and London Stansted Cambridge Consortium director John McGill at the Invest Glasgow Life Science seminar
Copyright © 2017 3Fox International Limited